TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/03/2026
Voltar para busca
Dado oficial do USPTO
ILIAS THERAPEUTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ILIAS THERAPEUTICS
ST13
US500000088776175Classe
1, 5, 9, 35, 42
Pedido
88776175
Registro
7033391
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
51
Atualização mais recente
18/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 35, 42
Data de depósito
28/01/2020
Data de registro
25/04/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
25/04/2023
Última transação
18/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
03
Localização do titular
Daejeon, KR
Examinador
FALK, ERIN
Unidade examinadora
L10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
ILIAS Biologics Inc.
Representantes
Janice Housey Litmus Law PLLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Diagnostic reagents and preparationsother than for medical or veterinary use; biologics in the nature of biological preparations for use in cell culturesother than for medical or veterinary use; chemical preparations for scientific purposesother than for medical or veterinary use; biochemical catalysts; biological preparations for use in industry and scienceother than for medical or veterinary purposes; bacterial preparations other than for medical and veterinary use; bacteriological preparations other than for medical and veterinary use; cultures of microorganismsother than for medical and veterinary use; industrial chemicals; diagnostic preparationsother than for medical or veterinary purposes; biological tissue cultures other than for medical or veterinary purposes; preparations of microorganismsother than for medical and veterinary use; adjuvantsother than for medical or veterinary purposes; reagent paperother than for medical or veterinary purposes; stem cells other than for medical or veterinary purposes; chemical reagentsother than for medical or veterinary purposes
Classe 5
Biochemicial drug for the treatment of cancermetabolic diseaseinflammatory diseasegenetic diseaseinfectious diseasescardiovascular diseaserespiratory diseaseneurological diseaseauto-immune diseasefibrosis disease; diagnostic reagents for medical purposes; pharmaceutical preparations for treating cancermetabolic diseaseinflammatory diseasegenetic diseaseinfectious diseasescardiovascular diseaserespiratory diseaseneurological diseaseauto-immune diseasefibrosis disease; stem cells for veterinary purposes; nutraceutical preparations for therapeutic or medical purposes for the treatment of cancermetabolic diseaseinflammatory diseasegenetic diseaseinfectious diseasescardiovascular diseaserespiratory diseaseneurological diseaseauto-immune diseasefibrosis disease; chemical preparations for pharmaceutical purposes for the treatment of cancermetabolic diseaseinflammatory diseasegenetic diseaseinfectious diseasescardiovascular diseaserespiratory diseaseneurological diseaseauto-immune diseasefibrosis disease; enzyme preparations for medical purposes; chemical preparations for medical purposes for the treatment of cancermetabolic diseaseinflammatory diseasegenetic diseaseinfectious diseasescardiovascular diseaserespiratory diseaseneurological diseaseauto-immune diseasefibrosis disease; diagnostic preparations for medical purposes; chemico-pharmaceutical preparations for the treatment of cancermetabolic diseaseinflammatory diseasegenetic diseaseinfectious diseasescardiovascular diseaserespiratory diseaseneurological diseaseauto-immune diseasefibrosis disease; chemical reagents for medical or veterinary purposes; preparations of microorganisms for medical and veterinary use for the treatment of cancermetabolic diseaseinflammatory diseasegenetic diseaseinfectious diseasescardiovascular diseaserespiratory diseaseneurological diseaseauto-immune diseasefibrosis disease; genetic identity tests comprised of reagents for medical purposes; biological preparations for medical purposes for the treatment of cancermetabolic diseaseinflammatory diseasegenetic diseaseinfectious diseasescardiovascular diseaserespiratory diseaseneurological diseaseauto-immune diseasefibrosis disease; biological preparations for veterinary purposes for the treatment of cancermetabolic diseaseinflammatory diseasegenetic diseaseinfectious diseasescardiovascular diseaserespiratory diseaseneurological diseaseauto-immune diseasefibrosis disease; bacteriological preparations for medical and veterinary use; biological reagents for clinical medical use; stem cells for medical purposes; drugs for medical purposes featuring drugs for the purpose of treating cancermetabolic diseaseinflammatory diseasegenetic diseaseinfectious diseasescardiovascular diseaserespiratory diseaseneurological diseaseauto-immune diseasefibrosis disease; medicines for human purposes featuring medicines for the purpose of treating cancermetabolic diseaseinflammatory diseasegenetic diseaseinfectious diseasescardiovascular diseaserespiratory diseaseneurological diseaseauto-immune diseasefibrosis disease; pharmaceutical preparations for the treatment of immune system related diseases and disorders; cell therapeutics for medical use
Classe 9
Electric bio-sensors; glassware for laboratory scientific experiments; incubator for laboratory use in cell culture; laboratory equipmentnamleyprotein sequence analysis equipment being laboratory apparatus; nucleic acid sequencers for scientific purposes for use in analyzing nucleic acide; petri dishes for laboratory use used in cell culture; bioreactor for cell culturing; apparatus for analyzing biochips for laboratory use; laboratory centrifuges; cell culture apparatus for laboratory usebioreactor for cell culturing; probes for scientific purposes; physical and chemical laboratory apparatus and instrumentsnamleyapparatus and instruments for cell culturing; particle foreign substances detectors for laboratory usedetectors used in cell culturing; ultrasonic sensors for molecular biology research in the nature of sensors used in cell culturing; bioreactors for laboratory use; microscopes for medical use; laboratory chemical reactors
Classe 35
Retail store services featuring pharmaceuticalveterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceuticalveterinary and sanitary preparations and medical supplies; retail and wholesale store services featuring drugs; retail and wholesale store services featuring veterinary drugs; retail and wholesale store services featuring pharmaceutical preparations; retail and wholesale store services featuring health preparations; retail and wholesale store services featuring medical supplies; retail and wholesale store services featuring preparations for veterinary use; sales promotion for others; marketing services
Classe 42
Research and development of technology for biotechnology in the nature of cell biology; biomedical research services; technological research in the field of cell biology; scientific research; biological research; laboratory research in the field of cell biology; scientific research and development; biological research and analysis; biotechnological research; cell separation research services; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; medical research; laboratory research in the field of pharmaceuticals; genetic testing for scientific research purposes; structural and functional analysis of genomes; medical laboratory services; stem cell research services; scientific laboratory services
Publicações
Histórico de despachos e eventos da marca no USPTO.
51 publicações encontradas
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
16/03/2026
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
16/03/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/03/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/03/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
16/03/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
16/03/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
25/04/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
25/04/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/02/2023
PUBO
PUBLISHED FOR OPPOSITION
07/02/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/01/2023
OTHE
CASE RETURNED TO EXAMINATION
20/12/2022
IUCN
NOTICE OF ALLOWANCE CANCELLED
20/12/2022
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
19/12/2022
ERTI
TEAS RESPONSE TO PETITION INQUIRY LETTER
19/12/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
17/12/2022
EX3G
SOU EXTENSION 3 GRANTED
15/12/2022
EXT3
SOU EXTENSION 3 FILED
15/12/2022
EEXT
SOU TEAS EXTENSION RECEIVED
15/12/2022
PILM
PETITION INQUIRY LETTER ISSUED
28/11/2022
APET
ASSIGNED TO PETITION STAFF
21/11/2022
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
06/11/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
17/06/2022
EX2G
SOU EXTENSION 2 GRANTED
15/06/2022
EXT2
SOU EXTENSION 2 FILED
15/06/2022
EEXT
SOU TEAS EXTENSION RECEIVED
15/06/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
17/12/2021
EX1G
SOU EXTENSION 1 GRANTED
15/12/2021
EXT1
SOU EXTENSION 1 FILED
15/12/2021
EEXT
SOU TEAS EXTENSION RECEIVED
15/12/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
15/06/2021
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
02/05/2021
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
08/01/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/12/2020
PUBO
PUBLISHED FOR OPPOSITION
22/12/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/12/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/11/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
18/11/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
18/11/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
18/11/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
18/11/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/10/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/10/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/10/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
27/04/2020
GNRT
NON-FINAL ACTION E-MAILED
27/04/2020
CNRT
NON-FINAL ACTION WRITTEN
27/04/2020
DOCK
ASSIGNED TO EXAMINER
16/04/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/02/2020
NWAP
NEW APPLICATION ENTERED
31/01/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ILIAS THERAPEUTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.